Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $20.8200 (0.97%) ($20.5800 - $21.0700) on Mon. Mar. 19, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.54% (three month average) | RSI | 68 | Latest Price | $20.8200(0.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(57%) IWO(56%) XBI(54%) IWM(52%) ARKG(50%) | Factors Impacting HALO price | HALO will decline at least -1.27% in a week (0% probabilities). UUP(-12%) VIXM(-11%) TLT(-7%) SHY(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.27% (StdDev 2.54%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
5 Day Moving Average | $20.87(-0.24%) | 10 Day Moving Average | $20.67(0.73%) | 20 Day Moving Average | $20.16(3.27%) | To recent high | -1.1% | To recent low | 22% | Market Cap | $2.846b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |